Edgen Stock·Dec 16 2025, 00:07Back
Gilead HIV Drug Succeeds In Phase 3 Trial
Edgen Stock·Dec 16 2025, 00:07
[1] Investigational weight-loss drug trial shows average reduced body weight of 30% - The Pharmaceutical Journal (https://pharmaceutical-journal.com/article/ne ...)[2] Argenyx’s Vyvgart Flops Phase III Thyroid Eye Disease Test, Raising Risk for Ongoing Trials - BioSpace (https://www.biospace.com/drug-development/arg ...)[3] Immunome Heads to the FDA With Desmoid Tumor Drug After Phase III Sweep - BioSpace (https://www.biospace.com/drug-development/imm ...)
